LOX promotes the growth of metastatic tumours through various mechanisms, including altering the extracellular matrix, attracting CD11b+ bone marrow cells, and facilitating their infiltration into the premetastatic microenvironment 28. The gene discussed is LOX; the disease is neoplasm.